Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Eur J Endocrinol. 2022 Jul 25;187(3):429–437. doi: 10.1530/EJE-22-0285

Table 3.

Presentation and outcomes of patients based on management. Data are presented as n (%) or as median (range).

Variable Management
P-value
Conservative Surgical

n 46 46
Age at diagnosis, years 50.8 (19–83) 36.9 (14–60) 0.0009
Women 24 (52%) 28 (61%) 0.5284
Symptoms of mass effect 2 (4%) 7 (15%) 0.1577
Initial cyst size, mm 45 (12–99) 50.5 (5–200) 0.3753
Unenhanced CT attenuation, HU 18 (0–83) 19 (0–70) 0.2892
Cyst growth rate#, mm per year +0.4 (−9 to 13) +5.5 (−8 to 27) 0.0002
Change in cyst size#,$, mm +2.3 (−60 to 73) +26 (−30 to 111) 0.0004

Abbreviations used: CT = computed tomography; HU = Hounsfield units

P value < 0.05 is significant

#

Available for 59 patients with more than 6 months of imaging follow-up

$

Difference between cyst size on last and the first imaging studies